# BridgeBio Pharma, Inc.: Form 8-K, filed Jun 24, 2024

- Company: [BridgeBio Pharma, Inc.](/companies/bbio.md) (CIK 1743881)
- Form: 8-K
- Filed: 2024-06-24
- Accepted by EDGAR: Jun 24, 2024, 16:01 ET
- Period: 2024-06-21
- Accession: 0001140361-24-031087
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1743881/000114036124031087/ef20031581_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1743881/000114036124031087/

## Items reported

- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1743881/000114036124031087/ef20031581_8k.htm

Filed Jun 24, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-031087. Last ingested by Listed: Nov 12, 2026, 17:56 ET. No prices; not investment advice.